eprinomectin component B1a
CHEBI:CHEBI_82597
Definition
An avermectin analogue that is avermectin A1a in which the methoxy group attached to the tetrahydrobenzofuranyl moiety is replaced by a hydroxy group and in which the hydroxy group at position 4 of the terminal 2,6-dideoxy-3-O-methyl-alpha-L-arabino-hyxopoyranosyl group is replaced by an acetamido group.
Chemical Information
- Molecular Formula
- C50H75NO14
- Molecular Mass
- 914.12880
- Charge
- 0
- SMILES
- CC[C@H](C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](NC(C)=O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)C=C[C@@H]1C
- InChI
- InChI=1S/C50H75NO14/c1-12-26(2)45-29(5)18-19-49(65-45)24-36-21-35(64-49)17-16-28(4)44(27(3)14-13-15-34-25-58-47-43(53)30(6)20-37(48(54)61-36)50(34,47)55)62-41-23-39(57-11)46(32(8)60-41)63-40-22-38(56-10)42(31(7)59-40)51-33(9)52/h13-16,18-20,26-27,29,31-32,35-47,53,55H,12,17,21-25H2,1-11H3,(H,51,52)/b14-13+,28-16+,34-15+/t26-,27-,29-,31-,32-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44-,45+,46-,47+,49+,50+/m0/s1
- InChIKey
- ZKWQQXZUCOBISE-NQMKODOQSA-N
Alternative Names
- (4''R)-4''-(acetylamino)-5-O-demethyl-4''-deoxyavermectin A1a
- eprinomectin B1a
- (2aE,4E,5'S,6S,6'R,7S,8E,11R,13S,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17-oxo-5',6,6',10,11,14,15,17,17a,20,20a,20b-dodecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-pyran]-7-yl 4-O-(4-acetamido-2,4,6-trideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranoside
Drug Classification
-
acetamidesView Class →
CHEBI:22160
-
semisynthetic derivativeView Class →
CHEBI:72588
-
organic heteropentacyclic compoundView Class →
CHEBI:38164
-
disaccharide derivativeView Class →
CHEBI:63353
-
spiroketalView Class →
CHEBI:72600
-
avermectin analogueView Class →
CHEBI:82599
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- oboInOwl#hasDbXref
- Reaxys:10325533
- core#notation
- CHEBI:82597
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- BFO_0000051
- http://purl.obolibrary.org/obo/CHEBI_82596
- owl#annotatedSource
- t303975
- owl#someValuesFrom
- t303742
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#hasDbXref
- Reaxys:10325533
- oboInOwl#id
- CHEBI:82597
- core#notation
- CHEBI:82597
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class